Investor mix
18 investors on record; lead investors include Newpath Partners, Atlas Venture, Google Ventures, Cormorant-asset.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 11 | 61% |
| Private equity | 1 | 6% |
| Other / undisclosed | 6 | 33% |
Developer of an epigenetic editing platform for genomic medicines
18 investors on record; lead investors include Newpath Partners, Atlas Venture, Google Ventures, Cormorant-asset.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 11 | 61% |
| Private equity | 1 | 6% |
| Other / undisclosed | 6 | 33% |